Hope is on the horizon as a new review indicates a growing number of potential treatments for Alzheimer’s disease.
The review, spearheaded by a University of Nevada expert and featured in the journal Alzheimer’s & Dementia: Translational Research and Clinical Interventions, highlights that 182 clinical trials are scheduled for 2025. This represents an 11% increase from the previous year, with 138 potential drugs being evaluated.